Search Results

LY2784544 5mg 5mg  | Purity Not Available

Adooq Bioscience

LY2784544 is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.

More Information Supplier Page

LY2784544 25mg 25mg  | Purity Not Available

Adooq Bioscience

LY2784544 is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.

More Information Supplier Page

LY2784544 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

LY2784544 is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.

More Information Supplier Page

LY2784544 100mg 100mg  | Purity Not Available

Adooq Bioscience

LY2784544 is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.

More Information Supplier Page